Human Milk Oligosaccharide 2'-Fucosyllactose Induces Neuroprotection from Intracerebral Hemorrhage Stroke

Int J Mol Sci. 2021 Sep 13;22(18):9881. doi: 10.3390/ijms22189881.

Abstract

Intracerebral hemorrhage (ICH) occurs when brain blood vessels rupture, causing inflammation and cell death. 2-Fucosyllactose (2FL), a human milk oligosaccharide, has potent antiapoptotic and anti-inflammatory effects. The purpose of this study was to examine the protective effect of 2FL in cellular and rodent models of ICH. Hemin was added to a primary rat cortical neuronal and BV2 microglia coculture to simulate ICH in vitro. IBA1 and MAP2 immunoreactivities were used to determine inflammation and neuronal survival. Hemin significantly increased IBA1, while it reduced MAP2 immunoreactivity. 2FL significantly antagonized both responses. The protective effect of 2FL was next examined in a rat ICH model. Intracerebral administration of type VII collagenase reduced open-field locomotor activity. Early post-treatment with 2FL significantly improved locomotor activity. Brain tissues were collected for immunohistochemistry and qRT-PCR analysis. 2FL reduced IBA1 and CD4 immunoreactivity in the lesioned striatum. 2FL downregulated the expression of ER stress markers (PERK and CHOP), while it upregulated M2 macrophage markers (CD206 and TGFβ) in the lesioned brain. Taken together, our data support that 2FL has a neuroprotective effect against ICH through the inhibition of neuroinflammation and ER stress. 2FL may have clinical implications for the treatment of ICH.

Keywords: 2-fucosyllactose; endoplasmic reticulum; inflammation; intracerebral hemorrhage stroke.

MeSH terms

  • Animals
  • Calcium-Binding Proteins / genetics*
  • Cell Line
  • Coculture Techniques
  • Collagenases / toxicity
  • Disease Models, Animal
  • Gene Expression Regulation
  • Hemin / toxicity
  • Hemorrhagic Stroke / chemically induced
  • Hemorrhagic Stroke / drug therapy*
  • Hemorrhagic Stroke / genetics
  • Hemorrhagic Stroke / pathology
  • Humans
  • Locomotion / drug effects
  • Microfilament Proteins / genetics*
  • Microglia / drug effects
  • Microglia / pathology
  • Microtubule-Associated Proteins / genetics*
  • Milk, Human / chemistry
  • Neurons / drug effects
  • Neurons / pathology
  • Neuroprotective Agents / chemistry
  • Neuroprotective Agents / pharmacology
  • Oligosaccharides / chemistry
  • Oligosaccharides / pharmacology
  • Rats
  • Trisaccharides / chemistry
  • Trisaccharides / pharmacology*

Substances

  • Aif1 protein, rat
  • Calcium-Binding Proteins
  • MAP2 protein, rat
  • Microfilament Proteins
  • Microtubule-Associated Proteins
  • Neuroprotective Agents
  • Oligosaccharides
  • Trisaccharides
  • Hemin
  • Collagenases
  • 2'-fucosyllactose